Identification of a Prognostic Index Based on a Metabolic-Genomic Landscape Analysis of Hepatocellular Carcinoma (HCC)

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Akinyemiju T, Abera S, Ahmed M, et al. The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: results From the Global Burden of Disease Study 2015. JAMA Oncol. 2017;3(12):1683–1691. doi:10.1001/jamaoncol.2017.305528983565
   PubMed Web of Science ®Google Scholar
• Li YK, Zou J, Ye DM, et al. Human p21-activated kinase 5 (PAK5) expression and potential mechanisms in relevant cancers: basic and clinical perspectives for molecular cancer therapeutics. Life Sci. 2020;241:117113. doi:10.1016/j.lfs.2019.11711331805288
   PubMed Web of Science ®Google Scholar
• Hollebecque A, Malka D, Ferté C, Ducreux M, Boige V. Systemic treatment of advanced hepatocellular carcinoma: from disillusions to new horizons. Eur J Cancer. 2015;51(3):327–339. doi:10.1016/j.ejca.2014.12.00525559615
   PubMed Web of Science ®Google Scholar
• Braicu C, Burz C, Berindan-Neagoe I, et al. Hepatocellular Carcinoma: tumorigenesis and Prediction Markers. Gastroenterology Res. 2009;2(4):191–199. doi:10.4021/gr2009.07.130427942274
   PubMedGoogle Scholar
• Nakagawa H, Umemura A, Taniguchi K, et al. ER stress cooperates with hypernutrition to trigger TNF-dependent spontaneous HCC development. Cancer Cell. 2014;26(3):331–343. doi:10.1016/j.ccr.2014.07.00125132496
   PubMed Web of Science ®Google Scholar
• Park EJ, Lee JH, Yu GY, et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell. 2010;140(2):197–208. doi:10.1016/j.cell.2009.12.05220141834
   PubMed Web of Science ®Google Scholar
• Nakagawa H. How endoplasmic reticulum stress contributes to obesity-driven hepatic tumorigenesis. Hepat Oncol. 2015;2(3):209–211. doi:10.2217/hep.15.1130191000
   PubMedGoogle Scholar
• Yoshimoto S, Loo TM, Atarashi K, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature. 2013;499(7456):97–101. doi:10.1038/nature1234723803760
   PubMed Web of Science ®Google Scholar
• Arano T, Nakagawa H, Tateishi R, et al. Serum level of adiponectin and the risk of liver cancer development in chronic hepatitis C patients. Int J Cancer. 2011;129(9):2226–2235. doi:10.1002/ijc.2586121170963
   PubMed Web of Science ®Google Scholar
• Shalapour S, Lin XJ, Bastian IN, et al. Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity. Nature. 2017;551(7680):340–345. doi:10.1038/nature2430229144460
   PubMed Web of Science ®Google Scholar
• Anstee QM, Reeves HL, Kotsiliti E, Govaere O, Heikenwalder M. From NASH to HCC: current concepts and future challenges. Nat Rev Gastroenterol Hepatol. 2019;16(7):411–428. doi:10.1038/s41575-019-0145-731028350
   PubMed Web of Science ®Google Scholar
• Ward PS, Thompson CB. Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate. Cancer Cell. 2012;21(3):297–308. doi:10.1016/j.ccr.2012.02.01422439925
   PubMed Web of Science ®Google Scholar
• Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029–1033. doi:10.1126/science.116080919460998
   PubMed Web of Science ®Google Scholar
• Budhu A, Roessler S, Zhao X, et al. Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes. Gastroenterology. 2013;144(5):1066–1075.e1. doi:10.1053/j.gastro.2013.01.05423376425
   PubMed Web of Science ®Google Scholar
• Tian Y, Yang B, Qiu W, et al. ER-residential Nogo-B accelerates NAFLD-associated HCC mediated by metabolic reprogramming of oxLDL lipophagy. Nat Commun. 2019;10(1):3391. doi:10.1038/s41467-019-11274-x31358770
   PubMed Web of Science ®Google Scholar
• Zhang Q, He Y, Luo N, et al. Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma. Cell. 2019;179(4):829–845.e20. doi:10.1016/j.cell.2019.10.00331675496
   PubMed Web of Science ®Google Scholar
• Lin P, Guo YN, Shi L, et al. Development of a prognostic index based on an immunogenomic landscape analysis of papillary thyroid cancer. Aging (Albany NY). 2019;11(2):480–500. doi:10.18632/aging.10175430661062
   PubMedGoogle Scholar
• Liu C-J, Hu -F-F, Xia M-X, Han L, Zhang Q, Guo A-Y. GSCALite: a web server for gene set cancer analysis. Bioinformatics. 2018;34(21):3771–3772. doi:10.1093/bioinformatics/bty41129790900
   PubMed Web of Science ®Google Scholar
• Su B, Su J, Zeng Y, et al. Diallyl disulfide suppresses epithelial-mesenchymal transition, invasion and proliferation by downregulation of LIMK1 in gastric cancer. Oncotarget. 2016;7(9):10498–10512. doi:10.18632/oncotarget.725226871290
   PubMedGoogle Scholar
• Geng X, Geng Z, Li H, Zhang Y, Li J, Chang H. Over-expression of TFB2M facilitates cell growth and metastasis via activating ROS-Akt-NF-κB signalling in hepatocellular carcinoma. Liver Int. 2020;40(7):1756–1769. doi:10.1111/liv.1444032174027
   PubMed Web of Science ®Google Scholar
• Makarona K, Caputo VS, Costa JR, et al. Transcriptional and epigenetic basis for restoration of G6PD enzymatic activity in human G6PD-deficient cells. Blood. 2014;124(1):134–141. doi:10.1182/blood-2014-02-55379224805191
   PubMed Web of Science ®Google Scholar
• Wang M, Wang L, Wu S, Zhou D, Wang X. Identification of Key Genes and Prognostic Value Analysis in Hepatocellular Carcinoma by Integrated Bioinformatics Analysis. Int J Genomics. 2019;2019:3518378. doi:10.1155/2019/351837831886163
   PubMed Web of Science ®Google Scholar
• Do Valle ÍF, Menichetti G, Simonetti G, et al. Network integration of multi-tumour omics data suggests novel targeting strategies. Nat Commun. 2018;9(1):4514. doi:10.1038/s41467-018-06992-730375513
   PubMed Web of Science ®Google Scholar
• Kroemer G, Pouyssegur J. Tumor cell metabolism: cancer’s Achilles’ heel. Cancer Cell. 2008;13(6):472–482. doi:10.1016/j.ccr.2008.05.00518538731
   PubMed Web of Science ®Google Scholar
• Huang Q, Tan Y, Yin P, et al. Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics. Cancer Res. 2013;73(16):4992–5002. doi:10.1158/0008-5472.Can-13-030823824744
   PubMed Web of Science ®Google Scholar
• Liang Q, Liu H, Wang C, Li B. Phenotypic Characterization Analysis of Human Hepatocarcinoma by Urine Metabolomics Approach. Sci Rep. 2016;6:19763. doi:10.1038/srep1976326805550
   PubMed Web of Science ®Google Scholar
• Xie Q, Fan F, Wei W, et al. Multi-omics analyses reveal metabolic alterations regulated by hepatitis B virus core protein in hepatocellular carcinoma cells. Sci Rep. 2017;7:41089. doi:10.1038/srep4108928112229
   PubMed Web of Science ®Google Scholar
• Jiang H, Liu J, Qin XJ, et al. Gas chromatography-time of flight/mass spectrometry-based metabolomics of changes in the urinary metabolic profile in osteoarthritic rats. Exp Ther Med. 2018;15(3):2777–2785. doi:10.3892/etm.2018.578829599826
   PubMed Web of Science ®Google Scholar
• Fages A, Duarte-Salles T, Stepien M, et al. Metabolomic profiles of hepatocellular carcinoma in a European prospective cohort. BMC Med. 2015;13:242. doi:10.1186/s12916-015-0462-926399231
   PubMed Web of Science ®Google Scholar
• Hamaguchi T, Iizuka N, Tsunedomi R, et al. Glycolysis module activated by hypoxia-inducible factor 1 alpha is related to the aggressive phenotype of hepatocellular carcinoma. Int J Oncol. 2008;33(4):725–731.18813785
   PubMed Web of Science ®Google Scholar
• Takashima M, Kuramitsu Y, Yokoyama Y, et al. Overexpression of alpha enolase in hepatitis C virus-related hepatocellular carcinoma: association with tumor progression as determined by proteomic analysis. Proteomics. 2005;5(6):1686–1692. doi:10.1002/pmic.20040102215800975
   PubMed Web of Science ®Google Scholar
• Stanton RC. Glucose-6-phosphate dehydrogenase, NADPH, and cell survival. IUBMB Life. 2012;64(5):362–369. doi:10.1002/iub.101722431005
   PubMed Web of Science ®Google Scholar
• Lu M, Lu L, Dong Q, et al. Elevated G6PD expression contributes to migration and invasion of hepatocellular carcinoma cells by inducing epithelial-mesenchymal transition. Acta Biochim Biophys Sin (Shanghai). 2018;50(4):370–380. doi:10.1093/abbs/gmy00929471502
   PubMed Web of Science ®Google Scholar
• Agarwal AK, Sukumaran S, Bartz R, Barnes RI, Garg A. Functional characterization of human 1-acylglycerol-3-phosphate-O-acyltransferase isoform 9: cloning, tissue distribution, gene structure, and enzymatic activity. J Endocrinol. 2007;193(3):445–457. doi:10.1677/joe-07-002717535882
   PubMed Web of Science ®Google Scholar
• Morita Y, Sakaguchi T, Ikegami K, et al. Lysophosphatidylcholine acyltransferase 1 altered phospholipid composition and regulated hepatoma progression. J Hepatol. 2013;59(2):292–299. doi:10.1016/j.jhep.2013.02.03023567080
   PubMed Web of Science ®Google Scholar
• Guo Z, Linn JF, Wu G, et al. CDC91L1 (PIG-U) is a newly discovered oncogene in human bladder cancer. Nat Med. 2004;10(4):374–381. doi:10.1038/nm101015034568
   PubMed Web of Science ®Google Scholar
• Cao J, Wang P, Chen J, He X. PIGU overexpression adds value to TNM staging in the prognostic stratification of patients with hepatocellular carcinoma. Hum Pathol. 2019;83:90–99. doi:10.1016/j.humpath.2018.08.01330171988
   PubMed Web of Science ®Google Scholar
• Chen Q, Li F, Gao Y, Xu G, Liang L, Xu J. Identification of Energy Metabolism Genes for the Prediction of Survival in Hepatocellular Carcinoma. Front Oncol. 2020;10:1210. doi:10.3389/fonc.2020.0121032903581
   PubMed Web of Science ®Google Scholar